$XTNT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Xtant Medical Holdings, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Xtant Medical Holdings, Inc.. Get notifications about new insider transactions in Xtant Medical Holdings, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 868,016 | 8,680 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 1,531,984 | 15,320 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 434,008 | 4,340 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 765,992 | 7,660 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 434,008 | 4,340 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | X | 0.01 | 765,992 | 7,660 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 868,016 | 8,680 | 17,036,720 | 16.2 M to 17 M (+5.37 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 434,008 | 4,340 | 16,168,704 | 15.7 M to 16.2 M (+2.76 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 434,008 | 4,340 | 15,734,696 | 15.3 M to 15.7 M (+2.84 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 1,531,984 | 15,320 | 55,766,352 | 54.2 M to 55.8 M (+2.82 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 765,992 | 7,660 | 54,234,368 | 53.5 M to 54.2 M (+1.43 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | X | 0.01 | 765,992 | 7,660 | 53,468,376 | 52.7 M to 53.5 M (+1.45 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | X | 0.01 | 868,016 | 8,680 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | X | 0.01 | 1,531,984 | 15,320 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | X | 0.01 | 434,008 | 4,340 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | X | 0.01 | 765,992 | 7,660 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | X | 0.01 | 434,008 | 4,340 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | X | 0.01 | 765,992 | 7,660 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Buy | X | 0.01 | 868,016 | 8,680 | 17,036,720 | 16.2 M to 17 M (+5.37 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Buy | X | 0.01 | 434,008 | 4,340 | 16,168,704 | 15.7 M to 16.2 M (+2.76 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Buy | X | 0.01 | 434,008 | 4,340 | 15,734,696 | 15.3 M to 15.7 M (+2.84 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Buy | X | 0.01 | 1,531,984 | 15,320 | 55,766,352 | 54.2 M to 55.8 M (+2.82 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Buy | X | 0.01 | 765,992 | 7,660 | 54,234,368 | 53.5 M to 54.2 M (+1.43 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Buy | X | 0.01 | 765,992 | 7,660 | 53,468,376 | 52.7 M to 53.5 M (+1.45 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | X | 0.01 | 868,016 | 8,680 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | X | 0.01 | 1,531,984 | 15,320 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | X | 0.01 | 434,008 | 4,340 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | X | 0.01 | 765,992 | 7,660 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | X | 0.01 | 434,008 | 4,340 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | X | 0.01 | 765,992 | 7,660 | 0 | |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Buy | X | 0.01 | 868,016 | 8,680 | 17,036,720 | 16.2 M to 17 M (+5.37 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Buy | X | 0.01 | 434,008 | 4,340 | 16,168,704 | 15.7 M to 16.2 M (+2.76 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Buy | X | 0.01 | 434,008 | 4,340 | 15,734,696 | 15.3 M to 15.7 M (+2.84 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Buy | X | 0.01 | 1,531,984 | 15,320 | 55,766,352 | 54.2 M to 55.8 M (+2.82 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Buy | X | 0.01 | 765,992 | 7,660 | 54,234,368 | 53.5 M to 54.2 M (+1.43 %) |
Nov 19 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Buy | X | 0.01 | 765,992 | 7,660 | 53,468,376 | 52.7 M to 53.5 M (+1.45 %) |
Oct 05 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Grant | A | 1.07 | 11,969,619 | 12,807,492 | 15,300,688 | 3.3 M to 15.3 M (+359.33 %) |
Oct 05 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Grant | A | 1.07 | 46,784,775 | 50,059,709 | 52,702,384 | 5.9 M to 52.7 M (+790.60 %) |
Aug 18 2020 | XTNT | Xtant Medical Hold ... | JENSEN GREG | VP, Finance and CFO | Option Exercise | A | 1.13 | 119,942 | 135,534 | 119,942 | |
Aug 18 2020 | XTNT | Xtant Medical Hold ... | JENSEN GREG | VP, Finance and CFO | Grant | A | 0.00 | 95,183 | 0 | 129,081 | 33.9 K to 129.1 K (+280.79 %) |
Aug 18 2020 | XTNT | Xtant Medical Hold ... | Brandt Kevin D | Chief Commercial Of ... | Option Exercise | A | 1.13 | 119,942 | 135,534 | 119,942 | |
Aug 18 2020 | XTNT | Xtant Medical Hold ... | Brandt Kevin D | Chief Commercial Of ... | Grant | A | 0.00 | 95,183 | 0 | 170,352 | 75.2 K to 170.4 K (+126.63 %) |
May 20 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 868,016 | 8,680 | 868,016 | |
May 20 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 1,531,984 | 15,320 | 1,531,984 | |
May 20 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | A | 0.01 | 868,016 | 8,680 | 868,016 | |
May 20 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | A | 0.01 | 1,531,984 | 15,320 | 1,531,984 | |
May 20 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | A | 0.01 | 868,016 | 8,680 | 868,016 | |
May 20 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | A | 0.01 | 1,531,984 | 15,320 | 1,531,984 | |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 70,423 | 0 | 91,256 | 20.8 K to 91.3 K (+338.04 %) |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 70,423 | 0 | 91,256 | 20.8 K to 91.3 K (+338.04 %) |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Grant | A | 0.00 | 70,423 | 0 | 91,256 | 20.8 K to 91.3 K (+338.04 %) |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Grant | A | 0.00 | 70,423 | 0 | 91,256 | 20.8 K to 91.3 K (+338.04 %) |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | Peters Jeffrey J | Director | Grant | A | 0.00 | 116,197 | 0 | 147,794 | 31.6 K to 147.8 K (+367.75 %) |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | McNamara Robert | Director | Grant | A | 0.00 | 116,197 | 0 | 146,057 | 29.9 K to 146.1 K (+389.14 %) |
Feb 07 2020 | XTNT | Xtant Medical Hold ... | BAKEWELL JOHN K | Director | Grant | A | 0.00 | 116,197 | 0 | 147,794 | 31.6 K to 147.8 K (+367.75 %) |
Oct 31 2019 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Grant | A | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Oct 31 2019 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Grant | A | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Oct 31 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Oct 31 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Oct 31 2019 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Grant | A | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Oct 15 2019 | XTNT | Xtant Medical Hold ... | Browne Sean E | President and CEO | Option Exercise | A | 2.70 | 329,044 | 888,419 | 329,044 | |
Oct 15 2019 | XTNT | Xtant Medical Hold ... | Browne Sean E | President and CEO | Grant | A | 0.00 | 329,044 | 0 | 329,044 | 0 to 329 K |
Sep 25 2019 | XTNT | Xtant Medical Hold ... | McNamara Robert | Director | Grant | A | 0.00 | 9,027 | 0 | 29,860 | 20.8 K to 29.9 K (+43.33 %) |
Sep 25 2019 | XTNT | Xtant Medical Hold ... | BAKEWELL JOHN K | Director | Grant | A | 0.00 | 5,555 | 0 | 31,597 | 26 K to 31.6 K (+21.33 %) |
Sep 25 2019 | XTNT | Xtant Medical Hold ... | Peters Jeffrey J | Director | Grant | A | 0.00 | 5,555 | 0 | 31,597 | 26 K to 31.6 K (+21.33 %) |
Aug 16 2019 | XTNT | Xtant Medical Hold ... | Brandt Kevin D | Chief Commercial Of ... | Option Exercise | A | 2.76 | 40,527 | 111,855 | 40,527 | |
Aug 16 2019 | XTNT | Xtant Medical Hold ... | Brandt Kevin D | Chief Commercial Of ... | Grant | A | 0.00 | 35,169 | 0 | 75,169 | 40 K to 75.2 K (+87.92 %) |
Aug 16 2019 | XTNT | Xtant Medical Hold ... | Brandt Kevin D | Chief Commercial Of ... | Option Exercise | A | 2.76 | 40,527 | 111,855 | 40,527 | |
Aug 16 2019 | XTNT | Xtant Medical Hold ... | Brandt Kevin D | Chief Commercial Of ... | Grant | A | 0.00 | 35,169 | 0 | 75,169 | 40 K to 75.2 K (+87.92 %) |
Aug 16 2019 | XTNT | Xtant Medical Hold ... | JENSEN GREG | VP, Finance & CFO | Option Exercise | A | 2.76 | 39,063 | 107,814 | 39,063 | |
Aug 16 2019 | XTNT | Xtant Medical Hold ... | JENSEN GREG | VP, Finance & CFO | Grant | A | 0.00 | 33,898 | 0 | 33,898 | 0 to 33.9 K |
Apr 03 2019 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | A | 0.01 | 434,008 | 4,340 | 434,008 | |
Apr 03 2019 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | A | 0.01 | 765,992 | 7,660 | 765,992 | |
Apr 03 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 434,008 | 4,340 | 434,008 | |
Apr 03 2019 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 765,992 | 7,660 | 765,992 | |
Jan 16 2019 | XTNT | Xtant Medical Hold ... | Berlin Ronald G. | VP & Chief Operatio ... | Option Exercise | A | 2.24 | 100,000 | 224,000 | 100,000 | |
Oct 15 2018 | XTNT | Xtant Medical Hold ... | Mainelli Michael | Interim CEO | Option Exercise | A | 3.22 | 240,000 | 772,800 | 240,000 | |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | A | 0.01 | 434,008 | 4,340 | 434,008 | |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Option Exercise | A | 0.01 | 765,992 | 7,660 | 765,992 | |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | A | 0.01 | 434,008 | 4,340 | 434,008 | |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Option Exercise | A | 0.01 | 765,992 | 7,660 | 765,992 | |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 434,008 | 4,340 | 434,008 | |
Sep 19 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 0.01 | 765,992 | 7,660 | 765,992 | |
Sep 18 2018 | XTNT | Xtant Medical Hold ... | Lenzen Kathie J. | Chief Financial Off ... | Option Exercise | A | 4.66 | 130,000 | 605,800 | 130,000 | |
Aug 16 2018 | XTNT | Xtant Medical Hold ... | Peters Jeffrey J | Director | Grant | A | 0.00 | 26,042 | 0 | 26,042 | 0 to 26 K |
Aug 16 2018 | XTNT | Xtant Medical Hold ... | O'Connell Carl | Chief Executive Off ... | Option Exercise | A | 6.20 | 200,000 | 1,240,000 | 200,000 | |
Aug 16 2018 | XTNT | Xtant Medical Hold ... | Brandt Kevin D | VP & Chief Commerci ... | Option Exercise | A | 6.20 | 30,770 | 190,774 | 30,770 | |
Aug 16 2018 | XTNT | Xtant Medical Hold ... | Brandt Kevin D | VP & Chief Commerci ... | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
May 04 2018 | XTNT | Xtant Medical Hold ... | McNamara Robert | Director | Grant | A | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Apr 10 2018 | XTNT | Xtant Medical Hold ... | BAKEWELL JOHN K | Director | Grant | A | 0.00 | 26,042 | 0 | 26,042 | 0 to 26 K |
Apr 10 2018 | XTNT | Xtant Medical Hold ... | Mainelli Michael | Director | Grant | A | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Apr 10 2018 | XTNT | Xtant Medical Hold ... | BAKEWELL JOHN K | Director | Grant | A | 0.00 | 26,042 | 0 | 26,042 | 0 to 26 K |
Apr 10 2018 | XTNT | Xtant Medical Hold ... | Mainelli Michael | Director | Grant | A | 0.00 | 20,833 | 0 | 20,833 | 0 to 20.8 K |
Feb 26 2018 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Buy | P | 7.20 | 342,132 | 2,463,350 | 3,316,128 | 3 M to 3.3 M (+11.50 %) |
Feb 26 2018 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Buy | P | 7.20 | 603,687 | 4,346,546 | 5,890,884 | 5.3 M to 5.9 M (+11.42 %) |
Feb 26 2018 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Grant | A | 7.20 | 2,905,396 | 20,918,851 | 2,973,996 | 68.6 K to 3 M (+4,235.27 %) |
Feb 26 2018 | XTNT | Xtant Medical Hold ... | Rizzo Matthew | Director | Grant | A | 7.20 | 5,126,534 | 36,911,045 | 5,287,197 | 160.7 K to 5.3 M (+3,190.86 %) |
Feb 26 2018 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Buy | P | 7.20 | 342,132 | 2,463,350 | 3,316,128 | 3 M to 3.3 M (+11.50 %) |
Feb 26 2018 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Buy | P | 7.20 | 603,687 | 4,346,546 | 5,890,884 | 5.3 M to 5.9 M (+11.42 %) |
Feb 26 2018 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Grant | A | 7.20 | 2,905,396 | 20,918,851 | 2,973,996 | 68.6 K to 3 M (+4,235.27 %) |
Feb 26 2018 | XTNT | Xtant Medical Hold ... | Eggenberg Michael | Director | Grant | A | 7.20 | 5,126,534 | 36,911,045 | 5,287,197 | 160.7 K to 5.3 M (+3,190.86 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 34.80 | 809,614 | 28,174,567 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 34.80 | 1,428,553 | 49,713,644 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 46.56 | 18,810,000 | 875,793,600 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 46.56 | 33,190,000 | 1,545,326,400 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | P | 7.20 | 342,132 | 2,463,350 | 3,316,128 | 3 M to 3.3 M (+11.50 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | P | 7.20 | 603,687 | 4,346,546 | 5,890,884 | 5.3 M to 5.9 M (+11.42 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Grant | A | 7.20 | 2,905,396 | 20,918,851 | 2,973,996 | 68.6 K to 3 M (+4,235.27 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Grant | A | 7.20 | 5,126,534 | 36,911,045 | 5,287,197 | 160.7 K to 5.3 M (+3,190.86 %) |
Jul 27 2017 | XTNT | Xtant Medical Hold ... | DEEDRICK JOHN ARTHUR | Director | Grant | A | 0.00 | 51,948 | 0 | 100,434 | 48.5 K to 100.4 K (+107.14 %) |
Jul 27 2017 | XTNT | Xtant Medical Hold ... | Mazzocchi Rudy A | Director | Grant | A | 0.00 | 51,948 | 0 | 51,948 | 0 to 51.9 K |
Jul 27 2017 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Grant | A | 0.00 | 51,948 | 0 | 318,641 | 266.7 K to 318.6 K (+19.48 %) |
Jul 27 2017 | XTNT | Xtant Medical Hold ... | LOPACH MICHAEL A | Director | Grant | A | 0.00 | 51,948 | 0 | 95,335 | 43.4 K to 95.3 K (+119.73 %) |
Jul 27 2017 | XTNT | Xtant Medical Hold ... | BUCKMAN PAUL | Director | Grant | A | 0.00 | 51,948 | 0 | 72,049 | 20.1 K to 72 K (+258.43 %) |
Jul 27 2017 | XTNT | Xtant Medical Hold ... | TIMKO ERIC BERNARD | Director | Grant | A | 0.00 | 51,948 | 0 | 51,948 | 0 to 51.9 K |
Nov 25 2016 | XTNT | Xtant Medical Hold ... | Goldberger Daniel S | Chief Executive Off ... | Option Exercise | X | 0.90 | 120,000 | 108,000 | 120,000 | |
Nov 25 2016 | XTNT | Xtant Medical Hold ... | Goldberger Daniel S | Chief Executive Off ... | Option Exercise | X | 0.75 | 120,000 | 90,000 | 0 | |
Nov 25 2016 | XTNT | Xtant Medical Hold ... | Goldberger Daniel S | Chief Executive Off ... | Buy | X | 0.75 | 120,000 | 90,000 | 135,510 | 15.5 K to 135.5 K (+773.69 %) |
Nov 23 2016 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Option Exercise | X | 0.90 | 150,000 | 135,000 | 150,000 | |
Nov 23 2016 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Option Exercise | X | 0.75 | 150,000 | 112,500 | 0 | |
Nov 23 2016 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | X | 0.75 | 150,000 | 112,500 | 266,693 | 116.7 K to 266.7 K (+128.54 %) |
Oct 11 2016 | XTNT | Xtant Medical Hold ... | O'Connell Carl | President | Option Exercise | A | 1.11 | 300,000 | 333,000 | 300,000 | |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | Mazzocchi Rudy A | Director | Option Exercise | A | 1.99 | 29,700 | 59,103 | 29,700 | |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | TIMKO ERIC BERNARD | Director | Option Exercise | A | 1.99 | 29,700 | 59,103 | 29,700 | |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | Kirschman David Louis | Director | Option Exercise | D | 0.00 | 40,000 | 0 | 0 | |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | Goodman David | Option Exercise | M | 0.00 | 11,764 | 0 | 0 | ||
Jul 06 2016 | XTNT | Xtant Medical Hold ... | Goodman David | Buy | M | 0.00 | 11,764 | 0 | 11,764 | 0 to 11.8 K | |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | DEEDRICK JOHN ARTHUR | Director | Option Exercise | M | 0.00 | 11,764 | 0 | 0 | |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | DEEDRICK JOHN ARTHUR | Director | Grant | A | 0.00 | 20,101 | 0 | 48,486 | 28.4 K to 48.5 K (+70.82 %) |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | DEEDRICK JOHN ARTHUR | Director | Buy | M | 0.00 | 11,764 | 0 | 28,385 | 16.6 K to 28.4 K (+70.78 %) |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | BUCKMAN PAUL | Director | Grant | A | 0.00 | 20,101 | 0 | 20,101 | 0 to 20.1 K |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | WICKWIRE JON M. | Option Exercise | M | 0.00 | 11,764 | 0 | 0 | ||
Jul 06 2016 | XTNT | Xtant Medical Hold ... | WICKWIRE JON M. | Buy | M | 0.00 | 11,764 | 0 | 43,011 | 31.2 K to 43 K (+37.65 %) | |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Option Exercise | M | 0.00 | 11,764 | 0 | 0 | |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Grant | A | 0.00 | 20,101 | 0 | 116,693 | 96.6 K to 116.7 K (+20.81 %) |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | M | 0.00 | 11,764 | 0 | 96,592 | 84.8 K to 96.6 K (+13.87 %) |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | LOPACH MICHAEL A | Director | Option Exercise | M | 0.00 | 11,764 | 0 | 0 | |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | LOPACH MICHAEL A | Director | Grant | A | 0.00 | 20,101 | 0 | 43,387 | 23.3 K to 43.4 K (+86.32 %) |
Jul 06 2016 | XTNT | Xtant Medical Hold ... | LOPACH MICHAEL A | Director | Buy | M | 0.00 | 11,764 | 0 | 23,286 | 11.5 K to 23.3 K (+102.10 %) |
May 10 2016 | XTNT | Xtant Medical Hold ... | Goldberger Daniel S | Chief Executive Off ... | Buy | P | 2.34 | 5,000 | 11,700 | 86,522 | 81.5 K to 86.5 K (+6.13 %) |
Dec 21 2015 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | L | 2.80 | 1,000 | 2,800 | 84,828 | 83.8 K to 84.8 K (+1.19 %) |
Dec 21 2015 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | L | 3.19 | 552 | 1,761 | 83,828 | 83.3 K to 83.8 K (+0.66 %) |
Dec 21 2015 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | L | 2.81 | 148 | 416 | 83,276 | 83.1 K to 83.3 K (+0.18 %) |
Dec 03 2015 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | P | 2.83 | 1,000 | 2,830 | 83,128 | 82.1 K to 83.1 K (+1.22 %) |
Dec 03 2015 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | P | 2.82 | 1,000 | 2,820 | 82,128 | 81.1 K to 82.1 K (+1.23 %) |
Dec 03 2015 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | P | 2.81 | 300 | 843 | 81,128 | 80.8 K to 81.1 K (+0.37 %) |
Dec 03 2015 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | P | 2.85 | 1,000 | 2,850 | 80,828 | 79.8 K to 80.8 K (+1.25 %) |
Nov 23 2015 | XTNT | Xtant Medical Hold ... | Kirschman David Louis | EVP & Chief Scienti ... | Buy | P | 3.04 | 1,000 | 3,040 | 1,701,063 | 1.7 M to 1.7 M (+0.06 %) |
Nov 23 2015 | XTNT | Xtant Medical Hold ... | Kirschman David Louis | EVP & Chief Scienti ... | Buy | P | 2.94 | 1,000 | 2,943 | 1,700,063 | 1.7 M to 1.7 M (+0.06 %) |
Nov 20 2015 | XTNT | Xtant Medical Hold ... | Swanson Kent L | Director | Buy | P | 3.00 | 4,976 | 14,928 | 79,828 | 74.9 K to 79.8 K (+6.65 %) |